44th week of 2013 patent applcation highlights part 58 |
Patent application number | Title | Published |
20130289196 | FILM FORMING FORMULATION FOR TEXTURED SURFACES - A film forming formulation and applicator device for use with the film forming formulation for obtaining sharp paint lines on textured surfaces is described. The formulation comprises a binder as a film forming component. The binder is selected from the group consisting of acrylic, styrene-butadiene rubber (SBR), polyvinyl acetate (PVAc), and ethylene-vinyl acetate (EVA). The binder comprises at least 90 percent by weight of the formulation. | 2013-10-31 |
20130289197 | RUBBER BLEND WITH IMPROVED ROLLING RESISTANCE BEHAVIOR - A rubber blend, particularly for pneumatic vehicle tires, harnesses, straps and hoses. The rubber blend includes at least one rubber blend A of a solid styrene-butadiene rubber with an average molecular weight M | 2013-10-31 |
20130289198 | Rubber-Modified Vinyl-Based Graft Copolymer, and Thermoplastic Resin Composition Including the Same - The present invention relates to a rubber-modified vinyl-based graft copolymer to which acrylic monomers containing a phenyl or phenoxy group are grafted in order to increase compatibility with a polycarbonate resin, and also relates to a thermoplastic resin composition including the rubber-modified vinyl-based graft copolymer. The thermoplastic resin composition according to the present invention can significantly improve appearance and high fluidity and can have high flowability and chemical resistance. | 2013-10-31 |
20130289199 | METHOD FOR OBTAINING A PIEZOELECTRIC LINER FOR A HIGH PRESSURE STORAGE VESSEL - The piezoelectric and barrier liner for a high-pressure storage vessel is made out of PVDF-TrFE copolymer and the amount of crystallinity in the liner material is over 30%, preferably 35% at least. | 2013-10-31 |
20130289200 | NOVEL HYDROPHILIC CHAIN TRANSFER AGENT AND END-MODIFIED STYRENE-BUTADIENE COPOLYMER USING THEM - Disclosed are a novel chain transfer agent having a trichloromethyl functional group bonded at an end thereof, an end-modified styrene-butadiene copolymer prepared by using the chain transfer agent, and an organic-inorganic composite obtained by mixing the end-modified styrene-butadiene copolymer with silica. The disclosed end-modified styrene-butadiene copolymer has a high affinity with silica because its end is modified with a hydrophilic chain transfer agent. Thus, the organic-inorganic composite including the mixture of the copolymer with silica is useful as a material for the manufacture of rubber products such as a tire, a sole, a rubber hose, or a rubber belt. | 2013-10-31 |
20130289201 | AQUEOUS PIGMENT DISPERSIONS BASED ON RANDOM POLYURETHANE DISPERSANTS - The present disclosure provides novel aqueous pigment dispersions containing an aqueous vehicle, a pigment and a random polyurethane copolymer as a dispersant. The random polyurethane copolymer contains short hard segments without any ionic group. Also disclosed is the use of these dispersions in an ink-jet ink. | 2013-10-31 |
20130289202 | POLYAMIC ACID RESIN COMPOSITION AND METHOD OF PRODUCING THE SAME - The disclosed polyamic acid resin composition contains (a) a polyamic acid represented by general formula (1) or (2), and (b) a solvent. (A, A′, C, C′ are end-capped polyamic acid blocks comprising diaminobenzanilide and pyromellitic dianhydride or benzophenone tetracarboxylic dianhydride, and B, or D, is a polyamic acid block comprising a repeating unit other than A, A′, or C, C′. | 2013-10-31 |
20130289203 | TRIAZINE RING-CONTAINING POLYMER AND FILM-FORMING COMPOSITION CONTAINING SAME - A polymer containing a repeating unit structure having a triazine ring such as, for example, that which is represented by formula (25): can exhibit alone high heat resistance, high transparency, high refractive index, high solubility and low volume shrinkage; and can be used as a component in a film-forming composition as appropriate. | 2013-10-31 |
20130289204 | POLYIMIDE POWDER, POLYIMIDE SOLUTION, AND METHOD FOR PRODUCING POLYIMIDE POWDER - It is possible to provide polyimide powder which has an average size of 25 μm or less and is free from metal impurities which would otherwise be produced due to abrasion of a machine used for mechanical milling. | 2013-10-31 |
20130289205 | RESIN COMPOSTION FOR LASER ENGRAVING, FLEXOGRAPHIC PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND PROCESS FOR PRODUCING SAME, AND FLEXOGRAPHIC PRINTING PLATE AND PROCESS FOR MAKING SAME - Disclosed is a resin composition for laser engraving, comprising: (Component A) a macroinitiator having a structure represented by any one of Formulae I to V below obtained by step-growth polymerization; and (Component B) a polymerizable compound. | 2013-10-31 |
20130289206 | Polymers Comprising Hydroxyl Groups And Ester Groups And Method For The Production Thereof - The invention relates to polymers comprising ester/hydroxyl groups, containing repetitive structural units of formulae (I) and (II) in blocks, alternating, or random sequence wherein D represents a direct bond between the polymer backbone and the hydroxyl group, a C | 2013-10-31 |
20130289207 | MEMBRANE LYTIC POLY(AMIDO AMINE) POLYMERS FOR THE DELIVERY OF OLIGONUCLEOTIDES - The present invention provides membrane lytic poly(amido amine) polymers, polyconjugates, compositions and methods for the delivery of oligonucleotides for therapeutic purposes. | 2013-10-31 |
20130289208 | Monovinylaromatic Polymer Composition Comprising a Polymer Made From Renewable Resources as a Dispersed Phase - A monovinylaromatic polymer composition can include a bio-sourced polymer dispersed phase and optionally a rubber dispersed phase. The bio-sourced polymer dispersed phase can be predominantly made of particles having a size of less than 10 μm. The monovinylaromatic polymer composition can be made by admixing a monovinylaromatic monomer, bio-sourced polymer, and optionally rubber at conditions effective to polymerize at least a part of the monovinylaromatic monomer and generate a compatibilizer. The monovinylaromatic polymer composition can be made by admixing a monovinylaromatic monomer, functionalized bio-sourced polymer(s) or mixtures of bio-sourced polymer(s) and functionalized bio-sourced polymer(s), and optionally rubber at conditions effective to polymerize at least a part of the monovinylaromatic monomer. The monovinylaromatic polymer composition can be made by blending, in the molten state, functionalized bio-sourced polymer(s) or mixtures of bio-sourced polymer(s) and functionalized bio-sourced polymer(s) with monovinylaromatic polymer, and optionally rubber. | 2013-10-31 |
20130289209 | INTERFACIAL POLYMER FOR RUBBER-SILICA NETWORK - Disclosed is an interfacial polymer for a network used as a coupling agent in mixing of rubber-silica. More particularly, the interfacial polymer for a rubber-silica network is a block copolymer containing a copolymer of conjugated diene and vinyl aromatic monomers, in which when used as a coupling agent in the mixing of synthetic rubber and silica (an inorganic material), the polymer enhances silica dispersibility within the rubber, and improves compatibility and processability, resulting in considerable improvement in the dynamic property as well as the mechanical property of the rubber, and when used in a tire, etc., it enhances automobile braking performance and reduces rolling resistance. | 2013-10-31 |
20130289210 | PRESSURE-SENSITIVE ADHESIVE COMPOSITION AND PRESSURE-SENSITIVE ADHESIVE SHEET - A pressure-sensitive adhesive composition, including an acrylic polymer produced by polymerizing a monomer component or a partial polymerization product of the monomer component. The monomer component includes alkyl (meth)acrylate having an alkyl group having 10 to 13 carbon atoms and a polar group-containing monomer other than a carboxyl group-containing monomer. A content of the alkyl (meth)acrylate is 40 wt % or more and less than 80 wt % with respect to a total amount (100 wt %) of the monomer component. A content of the polar group-containing monomer is 7 wt % or more with respect to the total amount of the monomer component. A total content of the polar group-containing monomer and an alicyclic monomer is 15 wt % or more with respect to the total amount of the monomer component. | 2013-10-31 |
20130289211 | CROSS-LINKED POLYMER PARTICLE FOR EPOXY RESIN, EPOXY RESIN COMPOSITION, AND EPOXY CURED MATERIAL - The invention discloses a cross-linked polymer particle for an epoxy resin, an epoxy resin composition containing the cross-linked polymer particle, the epoxy resin and a curing agent, and an epoxy cured material having qualities of colorless transparency and crack resistance as a result of curing the resin composition. The cross-linked polymer particle for the epoxy resin contains a (meth)acrylate monomer unit and a crosslinking monomer unit, wherein a volume average primary particle diameter is 0.5 to 10 μm, and a glass transition temperature of the monomer components excluding the crosslinking monomer is 30° C. or more by FOX formula calculation, and the refractivity at 23° C. is 1.490 to 1.510. | 2013-10-31 |
20130289212 | POLYOLEFIN RESIN COMPOSITION AND MOLDED ARTICLE CONTAINING THE SAME - There is provided a polyolefin resin composition capable of affording molded articles being superior in tensile elongation at break and impact resistance. The composition includes not less than 1 wt % and less than 80 wt % of a propylene polymer (I) that is a propylene homopolymer or a copolymer of propylene and at least one comonomer, the copolymer having more than 0 wt % and less than 20 wt % of structural units derived from the at least one comonomer, not less than 1 wt % and less than 80 wt % of a propylene copolymer (II) having 20 to 80 wt % of structural units derived from the comonomer and/or an ethylene copolymer (III) having a density of less than 940 kg/m | 2013-10-31 |
20130289213 | Polyethylene and Process for Production Thereof - This invention relates to a process for polymerizing olefins in which the amount of trimethylaluminum in a methylalumoxane solution is adjusted to be from 1 to 25 mol %, prior to use as an activator, where the mol % trimethylaluminum is determined by | 2013-10-31 |
20130289214 | CONTROLLED FREE-RADICAL POLYMERIZATION OF N-VINYL LACTAMS IN AN AQUEOUS MEDIUM - The present invention relates to a method for preparing a polymer based on N-vinyl lactam monomer units, which comprises a step (E) for controlled radical polymerization of a composition comprising:
| 2013-10-31 |
20130289215 | Clay Modified Rubber Composition and a Method for Manufacturing Same - A method to improve the cure properties of clay/rubber system. Clay has been exfoliated by ionic liquid surfactant and then added to rubber. The ionic liquid surfactant compatiblizes the clay and rubber and reduces gas permeability, without significantly impairing the rubber cure characteristics. | 2013-10-31 |
20130289216 | POLYMER FOR A GLASS IONOMER CEMENT - A process for producing a water-soluble, hydrolysis-stable, polymerizable polymer, comprising a) a step of copolymerizing a mixture comprising (i) a first copolymerizable monomer comprising at least one optionally protected carboxylic acid group and a first polymerizable organic moiety, and (ii) a second copolymerizable monomer comprising one or more optionally protected primary and/or secondary amino groups and a second polymerizable organic moiety, for obtaining an amino group containing copolymer; b) a step of coupling to the amino group containing copolymer a compound having a polymerizable moiety and a functional group reactive with an amino group of repeating units derived from the second copolymerizable monomer in the amino group containing copolymer obtained in the first step wherein the optionally protected amino group is deprotected, so that polymerizable pendant groups are linked to the backbone by hydrolysis-stable linking groups, and, optionally, a step of deprotecting the protected carboxylic acid group after step (a) or step (b), for obtaining a polymerizable polymer. | 2013-10-31 |
20130289217 | CONDUCTING AND SEMICONDUCTING ORGANIC MATERIALS - A polymer comprising a conducting or semiconducting segment coupled to a polymer segment having an insulating polymer backbone, the polymer further comprising a RAFT functional group coupled to the polymer segment, wherein there is no RAFT functional group in between the conducting or semiconducting segment and the polymer segment. | 2013-10-31 |
20130289218 | POLYCARBOXYLIC ACID DYE WITH LOW POLYMERIZATION DEGREE - The present invention provides a polycarboxylic acid dye with low polymerization degree, which is formed by using a macromolecule skeleton of polymaleic acid linked to an azo chromophore, an azo-metal complexation chromophore or an anthraquinone chromophore via a bridge group of amide or ester bond. The dye is useful for dyeing and printing leather, protein fiber, cellulose fiber and synthetic fiber. | 2013-10-31 |
20130289219 | PRESSURE-SENSITIVE ADHESIVES WITH TRIAZINE-EPOXY CROSSLINKING SYSTEM - A crosslinkable composition is described comprising an acid- and epoxy-functional copolymer, which when cross-linked with a triazine crosslinking agent provides a pressure-sensitive adhesive and pressure-sensitive adhesive articles. | 2013-10-31 |
20130289220 | Bioabsorbable Polymeric Compositions and Medical Devices - The present invention comprises a stent comprising a blend formed from a polymer. The polymer comprises poly-L-lactide, poly-D-lactide or mixtures thereof and a copolymer moiety comprising poly-L-lactide or poly-D-lactide linked with ε-caprolactone or trimethylcarbonate. The poly-L-lactide or poly-D-lactide sequence in the copolymer moiety is random with respect to the distribution of ε-caprolactone or trimethylcarbonate and the copolymer moiety molecular weight ranges from about 1.2 IV to about 4.8 IV. The meandering elements may be stretched to a modulus ranging from about 250000 PSI to about 550,000 PSI. One, two, three, n or all segments of the meandering element may have a decreased cross-sectional area and may have a wide-angle X-ray scattering (WAXS) 2θ values of ranging from about 1 to about 35 after stretching. The crystal properties of the bioabsorbable polymers may change during crimping and/or expansion allowing for improved mechanical properties such as tensile strength and slower degradation kinetics. | 2013-10-31 |
20130289221 | METHOD FOR PRODUCING ALIPHATIC POLYESTER HAVING INCREASED MOLECULAR WEIGHT - The present invention addresses the problem of providing a method for continuously and effectively producing an aliphatic polyester having an increased molecular weight by preventing evaporation of a diisocyanate when blending the diisocyanate with an aliphatic polyester prepolymer in a molten state at a temperature not lower than the melting point thereof so that the diisocyanate and the aliphatic polyester prepolymer are uniformly blended.
| 2013-10-31 |
20130289222 | POLYMER MANUFACTURING PROCESS - Embodiments relate to a relatively rapid transesterification process including transesterifying condensation polymers such as polyethylene terephthalate (PET), or other polyesters used in commerce, with a modifying monomer mix containing other monomers to manufacture new polymers containing the pre-condensed moieties. The process preferably only involves transesterification as a reaction mechanism. The process preferably produces a rapid buildup of molecular weight and/or polymer uniformity by the high temperature transesterification of the condensation polymer with the modifying monomer mixture. The process can be performed in any suitable vessel including an extrusion line, and it has the advantage of greatly reduced cycle times over currently used condensation polymer utilization processes such as the recycling of PET into other materials. | 2013-10-31 |
20130289223 | POLYMERIC COUPLING AGENTS AND PHARMACEUTICALLY-ACTIVE POLYMERS MADE THEREFROM - A pharmaceutically-active polymeric compound of the general formula (I), | 2013-10-31 |
20130289224 | Polycarbonate-Polysiloxane Copolymer, and Method for Preparing Same - A polycarbonate-polysiloxane copolymer includes a polysiloxane unit. The polycarbonate-polysiloxane copolymer can have superior melt flowability and ductility while maintaining high transparency and low haze. | 2013-10-31 |
20130289225 | ADHESIVE COMPOSITION, AND ADHESIVE SHEET, SEMICONDUCTOR APPARATUS-PROTECTIVE MATERIAL AND SEMICONDUCTOR APPARATUS USING THE SAME - There is disclosed an adhesive composition comprising the following Components (A), (B) and (C), wherein a minimum melt viscosity of the composition is less than 500 Pa·s, a temperature which gives the minimum melt viscosity is less than 200° C., and, a melt viscosity at 200° C. of the composition is 500 Pa·s or more: | 2013-10-31 |
20130289226 | Use of Hydrogen and an Organozinc Compound for Polymerization and Polymer Property Control - Methods of controlling polymerization reactions using a synergistic amount of hydrogen and an organozinc compound are disclosed. The resulting polymers have lower molecular weights and higher melt flow indices. | 2013-10-31 |
20130289227 | PROCESS OF MAKING MODIFIED METALLOCENE CATALYST, CATALYST PRODUCED AND USE THEREOF - Olefin polymerization catalysts or catalyst systems comprising a mixture, contact product, reaction product or complex comprising as elements or components: (A) at least one metallocene pre-catalyst compound or polymerization active metallocene compound; (B) at least one titanium containing metallocene compound; and when (A) is a metallocene pre-catalyst compound, (C) at least one activator; provided however: (I) the titanium-containing metallocene compound is inactive or substantially inactive for the polymerization of olefins prior to or concurrently with the use of the catalyst system for olefin polymerization. Also disclosed are processes for producing the catalyst system and polyolefins having desirable combinations of properties, including melt index and molecular weight distribution, which properties are particularly desirable for the manufacture of polyolefin film products, especially LLDPE film A preferred catalyst comprises a zirconium or hafnium metal containing metallocene, an inactivated titanocene and a SiO2 support carrier. | 2013-10-31 |
20130289228 | Procatalyst Composition with Alkoxypropyl Ester Internal Electron Donor and Polymer from Same - Disclosed herein are catalyst compositions and polymers, i.e., propylene-based polymers, produced therefrom. The present catalyst compositions include an internal electron donor with an alkoxypropyl ester. The present catalyst compositions improve catalyst selectivity. Propylene-based polymer produced from the present catalyst composition has a melt flow rate greater than 4 g/10 min. | 2013-10-31 |
20130289229 | CATALYSTS - A complex of formula (I): wherein M is zirconium or hafnium; each X is a sigma ligand; L is a divalent bridge selected from —R′ | 2013-10-31 |
20130289230 | PROCESS FOR THE PREPARATION OF A SOLID METALLOCENE CATALYST SYSTEM AND ITS USE IN POLYMERISATION OF OLEFINS - Process for the preparation of a solid olefin polymerisation catalyst system, comprising an organometallic compound of a transition metal of Group 3 to 10 of the Periodic Table (IUPAC 2007) in the form of solid particles comprising the steps of a) preparing a solution (A) comprising ai) a transition metal compound of Formula (I) LmRnMXq (I) wherein “M” is a transition metal of anyone of the groups 3 to 10 of the periodic table (IUPAC 2007), preferably a transition metal of anyone of the groups 4 to 6 of the periodic table (IUPAC 2007), more preferably titanium (Ti), zirconium (Zr) or hafnium (Hf), i.e. zirconium (Zr) or hafnium (Hf), each “X” is independently a monovalent σ-ligand, each “L” is independently an organic ligand which coordinates to the transition metal (M), “R” is a bridging group linking said organic ligands (L), “m” is 2 or 3, preferably 2, “n” is 0, 1 or 2, preferably 1, “q” is 1, 2 or 3, preferably 2, m+q is equal to the valency of the transition metal (M), a2) a cocatalyst comprising an element of group 13 of the Periodic Table (IUPAC 2007), preferably a cocatalyst (Co) comprising a compound of AI and a3) a solvent (A-1), b) preparing a liquid/liquid emulsion system by dispersing the solution (A) in a solvent (B) wherein bi) the solvent (B) constitutes the continuous phase of the emulsion and comprises a nonreactive fluorinated synthetic oil like a perfluoropolyether, a polytrichlorofluoroethylene, a fluorosilicone, or combinations thereof, having a viscosity at 20° C. of at least 10 cSt according to ASTM D445 b2) the solution (A) constitutes in the form of droplets the dispersed phase and b3) the transition metal compound of formula (I) and the cocatalyst (Co) are present in the droplets, c) solidifying said dispersed phase to convert said droplets to solid particles and d) optionally recovering said particles to obtain said catalyst system. | 2013-10-31 |
20130289231 | Catalyst Composition with Alkoxyalkyl Ester Internal Electron Donor and Polymer from Same - Disclosed herein are catalyst compositions and polymers, i.e., propylene-based polymers, produced therefrom. The present catalyst compositions include an internal electron donor with a compounded alkoxyalkyl ester and optionally a mixed external electron donor. The present catalyst compositions improve catalyst selectivity, improve catalyst activity, and/or improve hydrogen response. Propylene-based polymer produced from the present catalyst composition has a melt flow rate greater than 10 g/10 min. | 2013-10-31 |
20130289232 | NOVEL CYCLIC AMINE COMPOUND AND PROCESS FOR PRODUCING POLYURETHANE RESIN BY USING IT - To provide a novel cyclic amine compound and a process for producing a polyurethane resin by using it. A 3-hydroxy-1,5-diazabicyclo[3.2.2]nonane represented by the following formula (1), and a process for producing a polyurethane resin by using a catalyst for producing a polyurethane resin, which contains the 3-hydroxy-1,5-diazabicyclo[3.2.2]nonane. When the compound represented by the formula (1) has optical isomers, diastereomers or geometric isomers, the compound includes both a mixture of any of them and an isolated isomer of any of them. | 2013-10-31 |
20130289233 | REVERSIBLE CROSSLINKED POLYMERS - The present invention provides reversibly crosslinked polymers and methods for producing and using the same. In particular, reversibly crosslinked polymers of the invention comprise polyesters comprising thiol groups as crosslinking moieties. Oxidation of thiol groups affords crosslinked polymer comprising a disulfide linkage and reduction of the disulfide linkage provides non-crosslinked polymer. In some embodiments, polymers of the invention are degradable and are biocompatible. | 2013-10-31 |
20130289234 | METHOD FOR OBTAINING HIGH-TENACITY ARAMID YARN - The invention relates to a method for obtaining high-tenacity aramid yarn, wherein the yarn is made of a copolymer obtained from a mixture of monomers comprising DAPBI, an aromatic para-diamine, and an aromatic para-diacid, wherein the yarn is heated in at least two process steps, characterized in that in a first step the yarn is heated at a temperature of 200 to 360° C. at a tension of at least 0.2 cN/dtex, followed by a second step wherein the yarn is heated at a temperature of 370 to 500° C. at a tension of less than 1 cN/dtex. The invention further pertains to a multifilament aramid yarn spun from a sulfuric acid spin dope and having a tenacity of at least 2500 mN/tex. | 2013-10-31 |
20130289235 | MULTIFUNCTIONAL COMPOUNDS FOR FORMING CROSSLINKED BIOMATERIALS AND METHODS OF PREPARATION AND USE - Multifunctional compounds are provided that readily crosslink in situ to provide crosslinked biomaterials. The multifunctional compounds contain a single component having at least three reactive functional groups thereon, with the functional groups selected so as to be non-reactive in an initial environment and inter-reactive in a modified environment. Reaction of a plurality of the multifunctional compounds results in a three-dimensional crosslinked matrix. In one embodiment, a first functional group is nucleophilic, a second functional group is electrophilic, and at least one additional functional group is nucleophilic or electrophilic. Methods for preparing and using the multifunctional compounds, and kits including the multifunctional compounds are also provided. Exemplary uses for the multifunctional compounds include tissue augmentation, biologically active agent delivery, bioadhesion, and prevention of adhesions following surgery or injury. | 2013-10-31 |
20130289236 | ALKYLENE OXIDE POLYMERIZATION USING A DOUBLE METAL CYANIDE CATALYST COMPLEX AND A MAGNESIUM, GROUP 3 - GROUP 15 METAL OR LANTHANIDE SERIES METAL COMPOUND - Alkylene oxide polymerizations are performed in the presence of a double metal cyanide polymerization catalyst and certain magnesium, Group 3-Group 15 metal or lanthanide series metal compounds. The presence of the magnesium, Group 3-Group 15 metal or lanthanide series metal compound provides several benefits including more rapid catalyst activation, faster polymerization rates and the reduction in the amount of ultra high molecular weight polymers that are formed. The catalyst mixture is unexpectedly useful in making polyethers having low equivalent weights. | 2013-10-31 |
20130289237 | USE OF A NEW GENE CODING FOR A NEW MEMBER OF THE MCM2-8 FAMILY IN PHARMACEUTICAL COMPOSITIONS - An isolated antibody specifically binding the C-terminus part of the MCM9 protein, the C-terminus part of the MCM9 protein is one of the following sequences: the amino acids sequence from the position 391 to the position 1143 of the MCM9 proteins of the sequence as set forth in SEQ ID NO: 2 or 16, or the amino acids sequence from the position 391 to the position 1143 of the MCM9 protein of the sequence as set forth in SEQ ID NO: 8. | 2013-10-31 |
20130289238 | PAR4 AGONIST PEPTIDES - The present invention provides PAR4 agonist peptides. These peptides are useful for developing robust PAR4 receptor assays. | 2013-10-31 |
20130289239 | METHOD FOR CROSS-LINKING PEPTIDES - The present invention relates to a method for cross-linking peptides using an activated furan-moiety. In particular, the present invention provides a method for cross-linking peptides comprising the steps of: a) providing a composition comprising furan-peptides, said furan-peptides comprising at least one amino acid comprising a furan-moiety; b) contacting said composition comprising furan-peptides with second peptides, thereby obtaining a mixture comprising furan-peptides and second peptides; c) adding an activation signal to said mixture of step b), thereby activating said furan-peptides to activated furan-peptides, and d) reacting said activated furan-peptides with said second peptides, thereby cross-linking said activated furan-peptides with said second peptides. | 2013-10-31 |
20130289240 | Cyclin Based Inhibitors of CDK2 and CDK4 - Structural and functional analysis of peptide inhibitor binding to the cyclin D and cyclin A groove has been investigated and used to design peptides that provide the basis for structure-activity relationships, have improved binding and have potential for development as chemical biology probes, as potential diagnostics and as therapeutics in the treatment of proliferative diseases including cancer and inflammation. | 2013-10-31 |
20130289241 | METHOD FOR PREPARING EXENATIDE - A method for preparing exenatide by solid-phase synthesis, including: 1) mixing an Fmoc-Rink amide AM resin with a deprotecting agent to obtain a Rink amide AM resin; 2) condensing an Fmoc-Ser(tBu)-OH with the Rink amide AM resin to obtain an Fmoc-Ser(tBu)-Rink amide AM resin; 3) repeating the Fmoc deprotection and the condensation between an amino acid and a polypeptide on the resin, and condensing an amino acid with a polypeptide on the resin from the C-terminal to the N-terminal, to form a polypeptide resin; and 4) separating the polypeptide and the resin on the polypeptide resin. | 2013-10-31 |
20130289242 | METHOD FOR PRODUCING BIO-ACTIVE AGENT FOR THE PREVENTION OF DISEASE CAUSED BY WHITE SPOT SYNDROME BACULOVIRUS COMPLEX AND A BIO-ACTIVE AGENT DERIVED THEREOF - A method of producing an agent capable of eliciting immune response against White Spot Syndrome Baculovirus complex in crustaceans of Penaeidae family upon ingestion of the agent comprising the steps of introducing a vector containing genetic sequence of Seq. No 1 into an alga to transform the algae; and cultivating the transformed algae to express modified VP28 peptides according to the genetic sequence of Seq. No. 1 to obtain the agent. | 2013-10-31 |
20130289243 | COLLAGEN PRODUCING PLANTS AND METHODS OF GENERATING AND USING SAME - A method of producing collagen in a plant and plants producing collagen are provided. The method is effected by expressing in the plant at least one type of a collagen alpha chain in a manner enabling accumulation of the collagen alpha chain in a subcellular compartment devoid of endogenous P4H activity, thereby producing the collagen in the plant. | 2013-10-31 |
20130289244 | Dock-and-Lock (DNL) Complexes for Delivery of Interference RNA - Described herein are compositions and methods of use of targeted delivery complexes for delivery of siRNA to a disease-associated cell, tissue or pathogen. The targeted delivery complex comprises a targeting molecule, such as an antibody or fragment thereof, conjugated to one or more siRNA carriers. In preferred embodiments the siRNA carrier is a dendrimer or protamine and the targeting molecule is an anti-cancer antibody, such as hRS7. More preferably, the antibody or fragment is rapidly internalized into the target cell to facilitate uptake of the siRNA. Most preferably, the targeted delivery complex is made by the DNL technique. The compositions and methods are of use to treat a variety of disease states, such as cancer, autoimmune disease, immune dysfunction, cardiac disease, neurologic disease, inflammatory disease or infectious disease. | 2013-10-31 |
20130289245 | METHODS FOR PURIFICATION OF ALPHA-1-ANTITRYPSIN AND APOLIPOPROTEIN A-1 - This invention relates to protein separation and purification methods for both alpha-1-antitrypsin (AAT, also known as alpha-1 proteinase inhibitor, API, and A.sub.1-PI) and Apolipoprotein A-I (ApoA-1) from, for example, a fraction of human blood plasma. In certain embodiments, the invention provides methods for separating AAT from ApoA-1 at the initial stage of purification, so that the same starting material can be used as a source for both proteins. The methods further pertain to providing compositions of AAT and of ApoA-1 suitable for pharmaceutical use and are suitable for large-scale purification. | 2013-10-31 |
20130289246 | INFLUENZA VIRUS ANTIBODIES AND IMMUNOGENS AND USES THEREFOR - The present invention is directed to particular monoclonal antibodies and fragments thereof that find use in the detection, prevention and treatment of influenza virus infections. In particular, these antibodies may neutralize or limit the replication of influenza virus. Also disclosed are improved methods for producing such monoclonal antibodies, including novel immunogens for use in vaccination and production of protective immune responses. | 2013-10-31 |
20130289247 | SINGLE UNIT ION EXCHANGE CHROMATOGRAPHY ANTIBODY PURIFICATION - The present invention relates to a method for the purification of antibodies from a protein mixture produced in a bioreactor, at least comprising the steps of intermediate purification and polishing, wherein the intermediate and polishing step comprises in either order in-line anion exchange chromatography (AEX) chromatography and cation exchange chromatography (CEX) chromatography steps in flow-through mode. The present invention further relates to a single operational unit comprising both an anion exchange chromatography part and a cation exchange chromatography part in either order, which are serially connected, wherein the unit comprises an inlet at the upstream end of the first ion exchange chromatography part and an outlet at the downstream end of the second ion exchange chromatography part and wherein the unit also comprises an inlet between the first ion exchange chromatography part and the second ion exchange chromatography part. | 2013-10-31 |
20130289248 | ANTICOAGULANT ANTIDOTES - The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants. | 2013-10-31 |
20130289249 | SIMPLIFIED ONE-POT SYNTHESIS OF [18F]SFB FOR RADIOLABELING - A non-aqueous single pot synthesis of [ | 2013-10-31 |
20130289250 | ANTIBODY AGAINST THE CFR-1R - The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions. | 2013-10-31 |
20130289251 | BINDING AGENT - A binding agent of the Formula A-a′:a-S-b:b′-B:X(n), wherein A as well as B is a monovalent binder, a′:a as well as b:b′ is a binding pair wherein a′ and a do not interfere with the binding of b to b′ and vice versa, S is a spacer of at least 1 nm in length, :X denotes a functional moiety bound either covalently or via a binding pair to at least one of a′, a, b, b′ or S, (n) is an integer and at least 1, - represents a covalent bond, and the linker a-S-b has a length of 6 to 100 nm. Also disclosed are methods of producing such binding agent and certain uses thereof. | 2013-10-31 |
20130289252 | COMPOSITIONS AND METHODS FOR THE DELIVERY OF NITRIC OXIDE - H-NOX proteins are mutated to exhibit improved or optimal kinetic and thermodynamic properties for blood gas NO delivery. The engineered H-NOX proteins comprise mutations that impart altered NO or O | 2013-10-31 |
20130289253 | REVERSIBLE PROTEIN MULTIMERS, METHODS FOR THEIR PRODUCTION AND USE - Some aspects of this invention are based on the recognition that reversible protein multimers in which monomeric proteins are conjugated to a carrier molecule via chelation complex bonds are stable under physiological conditions and can be dissociated in a controlled manner under physiological, nontoxic conditions. Accordingly, such protein multimers are useful for a variety of in vitro, ex vivo, and in vivo application for research, diagnostics, and therapy. Some aspect of this invention provide reversible MHC protein multimers, and methods of using such multimers in the detection and/or isolation of specific T-cells or T-cell populations. Because reversible MHC multimers can efficiently be dissociated, the time of MHC binding to T-cell receptors, and, thus, T-cell receptor-mediated T-cell activation can be minimized. The use of reversible MHC multimers as provided herein, accordingly, allows for the detection and isolation of bona fide antigen-specific CD8+ T cells without inducing activation dependent cell death, including rare, therapeutically valuable T-cells expressing T-cell receptors binding tumor antigens with high affinity. Methods for the production and use of reversible multimers are also provided. | 2013-10-31 |
20130289254 | CELL ADHESIVE MATERIAL FOR BIOLOGICAL TISSUE - An object of the present invention is to provide a cell-adhesive material for biological tissues, in which the surface of a material for biological tissues (particularly metallic material) is modified strongly with a large amount of a cell-adhesive artificial peptide (P) that retains a biological activity. | 2013-10-31 |
20130289255 | METHOD TO INCREASE THE MOLECULAR WEIGHT OF WOOD MANNANS AND XYLANS COMPRISING AROMATIC MOIETIES - A method to increase the molecular weight of wood mannans and xylans comprising aromatic moieties comprises the steps: a) obtaining mannan and/or xylan from wood, b) subjecting the mannan/xylan to oxidizing conditions to convert at least a fraction of the aromatic groups into radicals and reacting said radicals with each other to obtain complexes of mannan/xylan with increased molecular weight. The method is easy and cost efficient and enables to upgrade small wood mannans and xylans that are important in the pulp and paper industry into larger mannans and xylans and more defined structures which makes their isolation easier and application areas broader. Another advantage is that separation of mannans and xylans from mannans and xylans with bound aromatic groups is provided. The wood mannans and xylans with increased molecular weight can be used for the manufacture of barrier films in packages, for instance for oxygen, liquids and gas. | 2013-10-31 |
20130289256 | FLUORESCENT PROBE - A compound represented by the formula (I) (R | 2013-10-31 |
20130289257 | FORMULATIONS FOR NUCLEIC ACID STABILIZATION ON SOLID SUBSTRATES - The present disclosure generally relates to dry solid matrices for the extraction, stabilization, and storage of nucleic acids, particularly RNA, in a dry format under ambient conditions for a prolonged period of time. Methods for collecting and recovering the nucleic acids stored in the dry solid matrix are also described. | 2013-10-31 |
20130289258 | METHODS OF INDUCING INSULIN PRODUCTION - The present invention provides a method of inducing insulin production in a cell by up-regulating a target gene involved in insulin production in said cell using an saRNA (short activating ribonucleic acid) which specifically down-regulates a target antisense RNA transcript present in said cell, wherein (i) said target RNA transcript is complementary to a sequence located on the coding strand of the target gene between 1000 nucleotides upstream and 1000 nucleotides downstream of the transcription start site of the target gene; and (ii) said sRNA is a single or double stranded RNA molecule up to 30 nucleotides in length comprising a sequence of at least 13 nucleotides which has at least 95% complementarity to a region of the target transcript. Also provided are certain saRNA molecules and uses thereof, particular medical uses, and induced cells and uses thereof. | 2013-10-31 |
20130289259 | APTAMER LABELLED WITH F-19 NUCLEUS FOR TARGETED MOLECULAR IMAGING BY MRI - Magnetic Resonance Imaging based on | 2013-10-31 |
20130289260 | NT5 AND NT6 ALTERNATIVE TRANSCRIPTS OF THE KLK8 GENE ENCODING KALLIKREIN 8 - Newly discovered alternative transcripts of the KLK8 gene encoding kallikrein 8, NT5 and NT6. The sequence of NT5 is set forth in SEQ ID NO:7, and the sequence of NT6 is set forth in SEQ ID NO:8. | 2013-10-31 |
20130289261 | THERAPEUTIC AND DIAGNOSTIC CLONED MHC-UNRESTRICTED RECEPTOR SPECIFIC FOR THE MUC1 TUMOR ASSOCIATED ANTIGEN - The invention provides an isolated nucleic acid encoding a receptor, other than an immunoglobulin, wherein the receptor binds to a MUC1 tumor antigen independently of an major histocompatibility complex (MHC). The invention provides a method of activating a signaling pathway and/or killing a cancer cell using a receptor that is similar to or is a T cell receptor | 2013-10-31 |
20130289262 | ACP Promoter - Isolated nucleotide sequences encoding a promoter of the Acyl Carrier Protein (“ACP”). | 2013-10-31 |
20130289263 | COMPOUND, NUCLEIC ACID, METHOD FOR PRODUCING NUCLEIC ACID, AND KIT FOR PRODUCING NUCLEIC ACID - A compound is represented by the following formula ( | 2013-10-31 |
20130289264 | Methods And Compositions For Analyzing Ahasl Genes - The invention relates to methods and compositions for analyzing plant acetohydroxy acid synthase large subunit (AHASL) genes. In particular, the invention relates to methods for the detection of wild-type AHASL alleles and mutant AHASL alleles that encode imidazolinone-tolerant AHASL proteins. The methods involve the use of PCR amplification and novel compositions comprising allele-specific and gene-specific primers to detect the presence of mutant and/or wild-type alleles present at the individual AHASL genes of a plant. Specifically, the methods and compositions are useful for analyzing the three AHASL genes of | 2013-10-31 |
20130289265 | METHODS AND COMPOSITIONS FOR EXTRACTION AND STORAGE OF NUCLEIC ACIDS - The present disclosure generally relates to solid matrices for the extraction, stabilization, and storage of nucleic acids, particularly RNA, in a dry format under ambient conditions for a prolonged period of time. Methods for extracting, collecting, and recovering nucleic acids from the solid compositions are also described. | 2013-10-31 |
20130289266 | Spiroannulated Nucleosides and Process for the Preparation Thereof - We claim a simple strategy for the synthesis of a collection of C(3′)-spirodihydroisobenzo- furannulated and C(3′)-spirodihydroisobenzo-furannulated nucleosides featuring a [2+2+2]-cyclotrimerization as the key reaction. The cyclotrimerization reactions are facile with the unprotected nucleosides having a diyne unit. When both alkynes of the diyne are terminal, the regioselectivity is poor. However, when one of the terminal alkynes is additionally substituted, the cyclotrimerizations are highly diaste reoselective. Since the key bicycloannulation is the final step, this strategy provides flexibility in terms of the alkynes and is thus amenable for the synthesis of a focussed small molecule library. | 2013-10-31 |
20130289267 | THERMALLY INHIBITED POLYSACCHARIDES - This invention relates to thermally inhibited polysaccharides and improved processes of preparing them, wherein the improvement is dehydrating the polysaccharides under increased pressure and/or increased effective oxygen concentrations to produce compositions of improved organoleptic properties, including color, flavor and odor. | 2013-10-31 |
20130289268 | PROCESS FOR TREATING BIOMASS - This invention is directed to a process for treating biomass. The biomass is treated with a biomass swelling agent within the vessel to swell or rupture at least a portion of the biomass. A portion of the swelling agent is removed from a first end of the vessel following the treatment. Then steam is introduced into a second end of the vessel different from the first end to further remove swelling agent from the vessel in such a manner that the swelling agent exits the vessel at a relatively low water content. | 2013-10-31 |
20130289269 | PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN - Crystalline polymorphous forms of rifaximin (INN), referred to as rifaximin α and rifaximin β, and a poorly crystalline form referred to as rifaximin γ, useful in the production of medicaments containing rifaximin for oral and topical use and obtained by means of a crystallization process carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a fixed temperature and for a fixed period of time, followed by a drying under controlled conditions until reaching a precise water content in the end product, are the object of the invention. | 2013-10-31 |
20130289270 | Amination of Aryl Alcohol Derivatives - Embodiments of the invention provide methods and materials for chemical cross-coupling reactions that utilize aryl alcohol derivatives as cross-coupling partners. Embodiments of the invention include methods for the amination of aryl sulfamates and carbamates, which are attractive cross-coupling partners, particularly for use in multistep synthesis. Illustrative embodiments include versatile means to use simple derivatives of phenol as precursors to polysubstituted aryl amines, as exemplified by a concise synthesis of the antibacterial drug linezolid. | 2013-10-31 |
20130289271 | PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY - Provided herein are Heteroaryl Compounds having the following structure: | 2013-10-31 |
20130289272 | METHODS FOR PRODUCING 1,5,7-TRIAZABICYCLO[4.4.0]DEC-5-ENE BY REACTION OF A DISUBSTITUTED CARBODIIMIDE AND DIPROPYLENE TRIAMINE - Methods for producing 1,5,7-triazabicyclo[4.4.0]dec-5-ene using a disubstituted carbodiimide, dipropylene triamine and optionally an ethereal solvent and/or an alcohol are disclosed. Use of 1,5,7-triazabicyclo[4.4.0]dec-5-ene produced by this method in an electrodepositable coating composition, and electrophoretic deposition of such coating onto a substrate to form a coated substrate, are also disclosed. | 2013-10-31 |
20130289273 | METHODS FOR PRODUCING 1,5,7-TRIAZABICYCLO[4.4.0]DEC-5-ENE BY REACTION OF A DISUBSTITUTED CARBODIIMIDE AND DIPROPYLENE TRIAMINE - Methods for producing 1,5,7-triazabicyclo[4.4.0]dec-5-ene using a disubstituted carbodiimide, dipropylene triamine and optionally an ethereal solvent and/or an alcohol are disclosed. Use of 1,5,7-triazabicyclo[4.4.0]dec-5-ene produced by this method in an electrodepositable coating composition, and electrophoretic deposition of such coating onto a substrate to form a coated substrate, are also disclosed. | 2013-10-31 |
20130289274 | 6-, 7-, OR 8-SUBSTITUTED QUINAZOLINONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME - Provided are quinazolinone compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed. | 2013-10-31 |
20130289275 | PROCESS FOR THE PREPARATION OF PRAZIQUANTEL - The present disclosure describes a novel, cost-effective process for preparation of a 4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino-[2,1-a]isoquinoline derivatives. Specifically, it discloses a process for the preparation of the anthelmintic drug praziquantel through the use of a novel intermediate, 2-[(2,2-dimethoxyethyl)benzyl amino]-N-phenethylacetamide. This present disclosure also describes a novel crystalline form of 4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinoline. | 2013-10-31 |
20130289276 | PROCESS FOR PREPARING AN INTERMEDIATE OF SITAGLIPTIN VIA ENZYMATIC CONVERSION - The invention provides a process for preparing 3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one (Formula I), into its racemic (R/S) form or any of its optically active (S) or (R) forms or enantiomeric excess mixture of any of the forms comprising:
| 2013-10-31 |
20130289277 | MEDICAMENT FOR TREATING MENTAL AND BEHAVIOURAL DISORDERS - The present invention relates to a medicament comprising lurasidone or a pharmaceutically acceptable acid addition salt thereof for treating pervasive developmental disorders and a method of the treatment thereof. | 2013-10-31 |
20130289278 | Methods for the synthesis of activated ethylfumarates and their use as intermediates - Disclosed embodiments relate to improved methods for the synthesis of activated fumarate intermediates and their use in chemical synthesis. Disclosed embodiments describe the synthesis of activated fumarate esters including those derived from activating groups including: 4-nitrophenyl, diphenylphosphoryl azide, pivaloyl chloride, chlorosulfonyl isocyanate, p-nitrophenol, MEF, trifluoroacetyl and chlorine, for example, ethyl fumaroyl chloride and the subsequent use of the activated ester in situ. Further embodiments describe the improved synthesis of substituted aminoalkyl-diketopiperazines from unisolated and unpurified intermediates allowing for improved yields and reactor throughput. | 2013-10-31 |
20130289279 | THIOCYANATO OR ISOTHIOCYANATO SUBSTITUTED NAPHTHALENE DIIMIDE AND RYLENE DIIMIDE COMPOUNDS AND THEIR USE AS N-TYPE SEMICONDUCTORS - Disclosed are thiocyanato or isothiocyanato substituted naphthalene diimide and rylene diimide compounds according to formula (I), use of these compounds as n-type semiconductors, methods of preparing these compounds, as well as various compositions, composites, and devices that incorporate these compounds. | 2013-10-31 |
20130289280 | NOVEL PHARMACEUTICAL FORMS, AND METHODS OF MAKING AND USING THE SAME - Crystalline salts, polymorphs, solvates, and hydrates of bicalutamide, 5-fluorouracil, donepezil, anastrozole, nelfinavir, mirtazapine, lansoprazole, and tamsulosin, or derivatives thereof are provided by the subject invention. Methods of making and using the same are also provided. | 2013-10-31 |
20130289281 | CRYSTALLINE FORM OF A BIPHENYL COMPOUND - The invention provides a crystalline 1,2-ethanedisulfonic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenylcarbamoyl)ethyl]piperidin-4-yl ester or a solvate thereof. This invention also provides pharmaceutical compositions comprising such a salt or prepared using such a salt; processes and intermediates for preparing such a salt; and methods of using such a salt to treat a pulmonary disorder. | 2013-10-31 |
20130289282 | THIN FILM TUBE REACTOR - A thin film tube reactor comprising a tube having a longitudinal axis, an inner cylindrical surface, a closed end and an open end, wherein the tube is rotatable about the longitudinal axis and wherein the angle of the longitudinal axis relative to the horizontal is variable between about 0 degrees and about 90 degrees. | 2013-10-31 |
20130289283 | FIPRONIL PRODUCTION PROCESS - An improved oxidation process for preparing 5-amino-3-cyano-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-trifluoromethylsulphinyl-pyrazole, of formula (I) is described. The process includes admixing 5-amino-3-cyano-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-trifluoromethylthiopyrazole of formula (II) with dichloroacetic acid and hydrogen peroxide in the presence of a strong acid. | 2013-10-31 |
20130289284 | RENEWABLE MODIFIED NATURAL COMPOUNDS - Provided are modified natural compounds that are produced, at least in part, from (A) at least one epoxidized and/or maleated natural fatty acid, or epoxidized and/or maleated natural oil, and (B) at least one lactam having at least one hydroxyl functional group, wherein the lactam may be in a blend with one or more optional alcohol(s). Among other properties, the modified natural compounds may exhibit dispersibility or solubility characteristics in water and/or alcohols. The invention further provides a wide variety of compositions comprising the modified natural compounds. | 2013-10-31 |
20130289285 | Apparatuses Including Support Member Modifications and Processes Related Thereto - Embodiments of an invention disclosed herein relate to apparatuses and processes related thereto including modifications of support members that significantly reduce the magnitude of stress at junctions between the support members and the shell walls of the apparatuses. | 2013-10-31 |
20130289286 | SELENIUM-BASED MONOMERS AND CONJUGATED POLYMERS, METHODS OF MAKING, AND USE THEREOF - Substituted selenophene monomers, and polymers and copolymers having units derived from a substituted selenophene are disclosed. Also provided are methods of making and using the same. | 2013-10-31 |
20130289287 | PROCESS FOR OBTAINING DRONEDARONE - The present invention provides a process for obtaining dronedarone or salts thereof characterized in that in an organic phase comprising one or more non-polar solvents, 5-amino-3-[4-(3-di-n-butylaminopropoxy)benzoyl]-2-n-butyl-benzofuran is reacted with methane sulfonyl chloride without the addition of a base. The invention also provides a process for obtaining intermediates of dronedarone environmentally friendly and industrially viable. | 2013-10-31 |
20130289288 | PROCESS FOR TREATING A CARRIER, A PROCESS FOR PREPARING A CATALYST, THE CATALYST, AND USE OF THE CATALYST - A process for treating a carrier, or a precursor thereof, to at least partly remove impurities from the carrier, or the precursor thereof, comprising: contacting the carrier, or the precursor thereof, with a treatment solution comprising a salt in a concentration of at most 0.05 molar, wherein the salt comprises a cation and an anion, and wherein the cation is selected from ammonium, phosphonium, organic cations and combinations thereof, and wherein the anion is selected from organic anions, inorganic carboxylates, oxyanions of elements from Groups IIIA through VIIA of the Periodic Table of Elements, and combinations thereof; and separating at least part of the treatment solution from the carrier, or the precursor thereof. | 2013-10-31 |
20130289289 | PROCESS FOR THE PRODUCTION OF LIPIDS FROM BIOMASS - Process for the production of lipids from biomass comprising polysaccharides. The biomass is subjected to acid hydrolysis to obtain a solid phase and an aqueous phase. The solid phase is subjected to acid or to enzymatic hydrolysis obtaining a further solid phase and a further aqueous phase. The aqueous phases obtained from both hydrolysis steps are subjected to fermentation with an oleaginous yeast. The obtained fermentation broth comprises oleaginous cellular biomass which is subjected to microfiltration for the isolation of lipids. Said lipids can be used in the production of biodiesel or green diesel. | 2013-10-31 |
20130289290 | METHOD FOR THE PRODUCTION OF CARBOXYLIC ACID ESTERS DURING A TRANSPORT - The present invention concerns a method for the production of carboxylic acid esters containing the steps:
| 2013-10-31 |
20130289291 | ESTOLIDE DERIVATIVES PREPARED FROM TRIGLYCERIDES - A process to prepare an estolide derivative composition comprises reacting a triglyceride having an unsaturation level of less than 0.1 m Eq/g and an alcohol having from 2 to 22 carbon atoms, under conditions such that a product including an oligomerized ester having residual hydroxyl groups is formed; and reacting the product with a capping agent under conditions such that an estolide derivative composition is formed. The compositions may exhibit desirably low pour point, desirable viscosity and thermoxidative stability, and a high level of renewable carbons, making them suitable for use as biolubricants, process fluids, plasticizers, or starting materials for polyurethane polymers. | 2013-10-31 |
20130289292 | MAGNETIC-CORED DENDRIMER, THE METHOD FOR PREPARING THE SAME, AND THE CONTAMINANT TREATMENT METHOD USING THE SAME - Provided is a magnetic-cored dendrimer represented by the following Chemical Formula | 2013-10-31 |
20130289293 | Method Of Forming An MT-Propyl Siloxane Resin - A method of forming an MT-propyl siloxane resin includes the steps of hydrolyzing propyl trichlorosilane in an excess of water to provide a T-propyl siloxane resin and capping the T-propyl siloxane resin formed from the hydrolysis of the propyl trichlorosilane with a silicon-containing M-group capping agent to form the MT-propyl siloxane resin. The MT-propyl siloxane resin is useful in a variety of personal care applications, and in particular, as an additive to personal care compositions. | 2013-10-31 |
20130289294 | ETHYLENICALLY UNSATURATED POLYMERIZABLE GROUPS COMPRISING POLYCARBOSILOXANE MONOMERS - The present application relates to novel monomers comprising polycarbosiloxane monomers useful in certain specific embodiments in the manufacture of devices. More particularly, the present application relates to certain ethylenically unsaturated free radical polymerizable monomers comprising polycarbosiloxane monomers. Even more particularly, the present application pertains to monomers comprising polycarbosiloxane monomers which further comprise at least two ethylenically unsaturated free radical polymerizable groups. | 2013-10-31 |
20130289295 | DIASTEREOSELECTIVE PREPARATION OF BICYCLO[2.2.2]OCTAN-2-ONE COMPOUNDS - The present invention relates to a new process for the diastereoselective preparation of (1R*,4R*,5S*,6S*)-6-hydroxy-5-arylbicyclo[2.2.2]octan-2-one compounds, the compounds of the formula (II), which may subsequently be further transformed to 5-aryl-bicyclo[2.2.2]oct-5-en-2-one compounds of the formula (I): | 2013-10-31 |